SEC Form 4 research
| Issuer | Metagenomi Therapeutics, Inc. |
|---|---|
| Tickers | MGX |
| Reporting owners | 18 |
| Officers and directors | 5 |
| Last public filing | 2026-09-11 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-11 | 2026-09-09 | Reid Laurence | P | 117 | $1.18 | Not reported |
| 2026-09-11 | 2026-09-09 | Reid Laurence | P | 19,883 | $1.17 | Not reported |
| 2026-09-10 | 2026-09-08 | Wein Matthew | S | 358 | $1.16 | Not reported |
| 2026-09-10 | 2026-09-08 | Irish Jian | S | 2,140 | $1.16 | Not reported |
| 2026-09-10 | 2026-09-08 | Wapnick Pamela | S | 1,911 | $1.16 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.